Houlihan Lokey Advises Avant Healthcare

Houlihan Lokey is pleased to announce that Avant Healthcare (Avant), a full-service medical communications company using high science, data-driven strategies, and innovative digital and creative capabilities to develop and facilitate impactful messaging to healthcare professionals, has been acquired by Real Chemistry, a leading provider of AI-driven insights and marketing and medical communications for the healthcare industry. The transaction closed on February 1, 2024. The terms of the transaction were not disclosed.

Founded in 1994 and headquartered in Carmel, Indiana, Avant provides solutions that span engagement across the entirety of the drug commercialization lifecycle, including medical affairs, promotional medical education, scientific strategy and consulting, and speaker development and management, working on behalf of many of the top clients in the life sciences industry.

Avant’s team will become part of Real Chemistry’s Medical Group, which together will have more than 450 experts in medical communications, medical education, medical affairs, and scientific visualization and work seamlessly with the company’s integrated communications, engagement, influencer and strategic commercial, and creative capabilities.

Real Chemistry’s mission is to transform what healthcare is into what it should be by leveraging the industry’s most advanced AI-powered insights, diverse expertise, and customer-centric ideas. Real Chemistry helps the healthcare industry better understand, reach, and engage patients and professionals—while creating healthcare experiences that span diagnosis to adherence—to ensure therapies meet and exceed their potential to impact lives.

Houlihan Lokey served as the exclusive financial advisor to Avant. This deal highlights Houlihan Lokey’s leading experience in the pharma commercialization space and represents the firm’s 23rd transaction in this sector since 2019.